Title : The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis - Kobayashi_2016_Int.J.Geriatr.Psychiatry_31_892 |
Author(s) : Kobayashi H , Ohnishi T , Nakagawa R , Yoshizawa K |
Ref : Int J Geriatr Psychiatry , 31 :892 , 2016 |
Abstract :
BACKGROUND: Comparative evidence for efficacy and safety of second-generation cholinesterase inhibitors (ChEIs) is still sparse. OBJECTIVES: The purpose of this research is to compare three ChEIs, donepezil, galantamine and rivastigmine, in patients with mild-to-moderate Alzheimer's disease (AD). |
PubMedSearch : Kobayashi_2016_Int.J.Geriatr.Psychiatry_31_892 |
PubMedID: 26680338 |
Kobayashi H, Ohnishi T, Nakagawa R, Yoshizawa K (2016)
The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis
Int J Geriatr Psychiatry
31 :892
Kobayashi H, Ohnishi T, Nakagawa R, Yoshizawa K (2016)
Int J Geriatr Psychiatry
31 :892